SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The 56 Point TA; Charts With an Attitude -- Ignore unavailable to you. Want to Upgrade?

To: RWS who wrote (77646)5/20/2025 4:11:16 PM
From: RWS1 Recommendation

Recommended By
Bonefish

  Respond to of 79483
 
Oncolytics Biotech's ( ONCY ) work represents a significant step forward in the fight against metastatic pancreatic cancer, addressing a critical need for more effective treatment options in this aggressive disease. By leveraging the innovative potential of pelareorep in combination with established therapies, the company is paving the way for breakthroughs that could transform outcomes for patients and unlock value for investors.

??

RWS



To: RWS who wrote (77646)5/21/2025 7:56:48 AM
From: Magnatizer1 Recommendation

Recommended By
Gary1046

  Read Replies (1) | Respond to of 79483
 
Cci cross play (reverse of trend). By rules I should wait for the break of the high. I tend to front run them when the prevailing trend is clear in one direction as is the case with oncy here.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News